Functional recovery in parkinsonian monkeys treated with GDNF

Gash, Don M., Zhang, Zhiming, Ovadia, Aliza, Cass, Wayne A., Yi, Ai, Simmerman, Linda, Russell, Deborah, Martin, David, Lapchak, Paul A., Collins, Frank, Hoffer, Barry J., Gerhard, Greg A.·1996·Nature
DOI 10.1038/380252a0

Cited by (946)

Items 701–800 of 946

  1. Present and future directions in the management of motor complications in patients with advanced PD
    C. Warren Olanow · 2003 · Neurology
  2. In vitro assessment of neurotrophic activity from the striatum of aging rats
    Paul A. Kaseloo, Agnieszka Lis, Hideo Asada, Tara A. Barone, Robert J. Plunkett · 1996 · Neuroscience Letters
  3. Long-term intracerebral infusion of fibroblast growth factors restores motility and enhances F-DOPA uptake in parkinsonian monkeys
    Justo Garcı́a de Yébenes, Rosario Sánchez‐Pernaute, José Marı́a Garrido, Alberto Rábano, Julio Albísua, Ana Rojo, María A. Mena, Pedro Ruiz, Pablo Jorge, Carlos Corrêa et al. · 1998 · Parkinsonism & Related Disorders
  4. Neuroendocrine Mechanisms of Acupuncture
    Feng-Xia Liang, Rui Chen, Edwin Lowell Cooper · 2012 · Evidence-based Complementary and Alternative Medicine
  5. Indirect influence on the BDNF/TrkB receptor signaling pathway via GPCRs, an emerging strategy in the treatment of neurodegenerative disorders
    Mirjana Antonijevic, Patrick Dallemagne, Christophe Rochais · 2024 · Medicinal Research Reviews
  6. Modulation of nigral dopamine signaling mitigates parkinsonian signs of aging: evidence from intervention with calorie restriction or inhibition of dopamine uptake
    Michael F. Salvatore, Ella Anle Kasanga, D. Parker Kelley, Katy E. Venable, Tamara R. McInnis, Mark A. Cantu, Jennifer Terrebonne, Kathryn Lanza, Samantha M. Meadows, Ashley Centner et al. · 2022 · GeroScience
  7. Effects of Amphotericin B on the expression of neurotoxic and neurotrophic factors in cultured microglia
    Akiko Motoyoshi, Hidemitsu Nakajima, Katsura Takano, Mitsuaki Moriyama, Yukiko Kannan, Yoichi Nakamura · 2008 · Neurochemistry International
  8. Glial cell-line derived neurotrophic factor is essential for electroconvulsive shock-induced neuroprotection in an animal model of Parkinson's disease
    Agustín Anastasía, José Wojnacki, Gabriel A. de Erausquin, Daniel Hugo Mascó · 2011 · Neuroscience
  9. Improved methods for electroacupuncture and electromyographic recordings in normal and parkinsonian rhesus monkeys
    Feng Zhao, Xiaotong Fan, Richard Grondin, Ramsey Edwards, Eric Forman, Jennifer Moorehead, Greg A. Gerhardt, Xiaomin Wang, Zhiming Zhang · 2010 · Journal of Neuroscience Methods
  10. Possible Roles of Epigenetics in Stem Cell Therapy for Parkinson’s Disease
    Cassandra Thompson, Paulina Otero, Bhairavi Srinageshwar, Robert B. Petersen, Gary Leo Dunbar, Julien Rossignol · 2020 · Epigenomics
  11. gdnf affects early diencephalic dopaminergic neuron development through regulation of differentiation‐associated transcription factors in zebrafish
    Chee Ern David Wong, Khang Hua, Simon Monis, Vishal Saxena, Anwar Norazit, Suzita Mohd Noor, Marc Ekker · 2020 · Journal of Neurochemistry
  12. Complications of a trophic xenotransplant approach in parkinsonian monkeys
    Pierre J. Blanchet, Spyridon Konitsiotis, Hideki Mochizuki, Ryszard M. Pluta, Dwaine F. Emerich, Thomas N. Chase, M. Maral Mouradian · 2003 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  13. GDNF partially protects grafted fetal dopaminergic neurons against 6-hydroxydopamine neurotoxicity
    David M. Yurek, Anita M. Fletcher · 1999 · Brain Research
  14. Neurotrophic Factors
    Mark H. Tuszynski · 1999 · Elsevier eBooks
  15. Neuropathology of the Basal Ganglia in SNCA Transgenic Rat Model of Parkinson’s Disease: Involvement of Parvalbuminergic Interneurons and Glial-Derived Neurotropic Factor
    Emanuela Paldino, Vincenza D’Angelo, Mariangela Massaro Cenere, Ezia Guatteo, Simone Barattucci, Giorgia Migliorato, Nicola Berretta, Olaf Rieß, Giuseppe Sancesario, Nicola Biagio Mercuri et al. · 2022 · International Journal of Molecular Sciences
  16. Decreased face primary motor cortex (face-M1) excitability induced by noxious stimulation of the rat molar tooth pulp is dependent on the functional integrity of face-M1 astrocytes
    L. Awamleh, Henry Pun, Jye‐Chang Lee, Limor Avivi‐Arber · 2015 · Experimental Brain Research
  17. Enhancement of Striatal Dopaminergic Function Following Autologous Neural Cell Ecosystems (ANCE) Transplantation in a Non-Human Primate Model of Parkinson’s Disease
    Simon Borgognon, Jérôme Cottet, Véronique Moret, Pauline Chatagny, Nathalie Ginovart, Cristian Antonescu, Jocelyne Bloch, Jean-François Brunet Brunet, Eric M. Rouiller, Simon Badoud · 2017 · Journal of Alzheimer’s Disease & Parkinsonism
  18. GFR-α1 Expression in Substantia Nigra Increases Bilaterally Following Unilateral Striatal GDNF in Aged Rats and Attenuates Nigral Tyrosine Hydroxylase Loss Following 6-OHDA Nigrostriatal Lesion
    Ella Anle Kasanga, Catherine L. Owens, Mark A. Cantu, Adam D. Richard, Richard W. Davis, Lisa M. McDivitt, Blake Blancher, Brandon Scott Pruett, Christopher Tan, Austin Gajewski et al. · 2019 · ACS Chemical Neuroscience
  19. A Novel Animal Model of Parkinson’s Disease Using Optogenetics: Representation of Various Disease Stages by Modulating the Illumination Parameter
    Eun Jung Lee, Hyung Ho Yoon, Eun Suk Park, Joongkee Min, Sang Ryong Jeon · 2018 · Stereotactic and Functional Neurosurgery
  20. NEUROTROPHIC FACTORS
    Eugene M. Johnson, Mark H. Tuszynski · 2008 · Elsevier eBooks
  21. Lentiviral mediated gene delivery as an effective therapeutic approach for Parkinson disease
    Violina Kakoty, K C Sarathlal, Sunil Kumar Dubey, Chih Hao Yang, Prashant Kesharwani, Rajeev Taliyan · 2021 · Neuroscience Letters
  22. Gene therapy approaches for the treatment of Parkinson's disease
    B DASS, Jeffrey H. Kordower · 2007 · Handbook of clinical neurology
  23. Protective and Regenerative Properties of GDNF in the Central Nervous System
    Wayne A. Cass, Cecilia M. Kearns, Don Marshall Gash · 1998 · Humana Press eBooks
  24. Bridging between transplantation therapy and neurotrophic factors in Parkinson s disease
    George M. Smith · 2014 · Frontiers in Bioscience-Elite
  25. Neuropharmacologic Approaches to Restore the Brain’s Microenvironment
    Weizhe Li, Hsin-I Tong, Santhi Gorantla, Larisa Y. Poluektova, Howard Eliot Gendelman, Yuanan Lu · 2016 · Journal of Neuroimmune Pharmacology
  26. Sequestration of Inflammation in Parkinson’s Disease via Stem Cell Therapy
    Jonah Gordon, Gavin Lockard, Molly Monsour, Adam Alayli, Hassan Choudhary, Cesar V. Borlongan · 2022 · International Journal of Molecular Sciences
  27. Glial cell line-derived neurotrophic factor gene therapy ameliorates chronic hyperprolactinemia in senile rats
    G.R. Morel, Y. E. Sosa, María José Bellini, Néstor Gabriel Carri, Silvia Susana Rodríguez, Martha Churchill Bohn, Rodolfo G. Goya · 2010 · Neuroscience
  28. Effect of nigrostriatal damage induced by 6-hydroxydopamine on the expression of glial cell line–derived neurotrophic factor in the striatum of the rat
    Birgit Mertens, Ann Massie, Yvette Madeleine Michotte, Sophie Sarre · 2009 · Neuroscience
  29. Neuroreplacement, Growth Factor, and Small Molecule Neurotrophic Approaches for Treating Parkinson's Disease
    Michael J. O’Neill, Marcus J. Messenger, Viktor Lakics, Tracey K. Murray, Eric H. Karran, Philip G. Szekeres, Eric S. Nisenbaum, Kalpana Merchant · 2006 · International review of neurobiology
  30. Performance Tests for Wireless Real-Time Localization Systems to Improve Mobile Robot Navigation in Various Indoor Environments
    Yong K., Jong-Hoon Youn, Nam Pham · 2008 · InTech eBooks
  31. Future Trends in the Development of Local Drug Delivery Systems: Intraspinal, Intracerebral, and Intraparenchymal Therapies
    Elliot S. Krames, Eric Buchser, Samuel J. Hassenbusch, Robert M. Levy · 1999 · Neuromodulation Technology at the Neural Interface
  32. Pharmacological approaches to disease-modifying therapies in Parkinson’s disease
    Michael J. O’Neill, Eric Siemers · 2002 · Expert Review of Neurotherapeutics
  33. Augmented methamphetamine-induced overflow of striatal dopamine 1 day after GDNF administration
    Wayne A. Cass, Doriann J Walker, Michael W. Manning · 1999 · Brain Research
  34. Gene Therapy for the Treatment of Parkinson’s Disease: The Nature of the Biologics Expands the Future Indications
    Massimo S. Fiandaca, Krystof S. Bankiewicz, Howard J. Federoff · 2012 · Pharmaceuticals
  35. Induction of GAP‐43 modulates neuroplasticity in PBSC (CD34 + ) implanted‐Parkinson's model
    Woei‐Cherng Shyu, Kuo‐Wei Li, Hsiao‐Fen Peng, Shinn‐Zong Lin, Ren‐Shyan Liu, Hsiao‐Jung Wang, Ching‐Yuan Su, Yih‐Jing Lee, Hung Li · 2009 · Journal of Neuroscience Research
  36. The Effects of Progesterone on Glial Cell Line-derived Neurotrophic Factor Secretion from C6 Glioma Cells.
    Parichehr Hassanzadeh, Elham Arbabi · 2012 · Europe PMC (PubMed Central)
  37. Increased glial‐derived neurotrophic factor in the small intestine of rats infected with the tapeworm, Hymenolepis diminuta
    Wilma Aparecida Starke‐Buzetti, John Adams Oaks · 2008 · International Journal of Experimental Pathology
  38. Gene therapy for Parkinson’s disease
    Hoang Le, David M. Frim · 2002 · Expert Opinion on Biological Therapy
  39. Restorative Surgical Therapies for Parkinson's Disease
    Roy A.E. Bakay, Jeffrey H. Kordower, Philip A. Starr · 1999 · Elsevier eBooks
  40. Chronic sparing of delayed alternation performance and choline acetyltransferase activity by CEP-1347/KT-7515 in rats with lesions of nucleus basalis magnocellularis
    Amy DiCamillo, Nicola T. Neff, Susan Carswell, Forrest Haun · 1998 · Neuroscience
  41. Neurotrophic factor therapy — Keeping score
    Franz F. Hefti · 1997 · Nature Medicine
  42. Adult Neurogenesis in Parkinson’s Disease
    Hideki Mochizuki · 2011 · Springer eBooks
  43. Multiple Endocrine Neoplasia Type 2: Molecular Aspects
    Lois M. Mulligan · 2001 · KARGER eBooks
  44. In VivoAdenovirus-Mediated Gene Transfer for Parkinson's Disease
    Philippe Horellou, Alicia Bilang‐Bleuel, Jacques J. Mallet · 1997 · Neurobiology of Disease
  45. The Use of MicroPET for the Development of Neural Repair Therapeutics: Studies in Epilepsy and Lesion Models
    Harley I. Kornblum, Simon R. Cherry · 2001 · The Journal of Clinical Pharmacology
  46. Mesencephalic Human Neural Progenitor Cells Transplanted into the Adult Hemiparkinsonian Rat Striatum Lack Dopaminergic Differentiation but Improve Motor Behavior
    Marine Hovakimyan, Stefan Jean-Pierre Haas, Oliver Schmitt, Bernd Gerber, Andreas Wree, Christian Andressen · 2008 · Cells Tissues Organs
  47. Motility phenotype in a zebrafish vmat2 mutant
    Hildur Sóley Sveinsdóttir, Amanda R. Decker-Farrell, Christian Christensen, Pablo Botella Lucena, Haraldur S. Thorsteinsson, Elena Richert, Valerie Helene Maier, Robert A. Cornell, Karl Æ. Karlsson · 2022 · PLoS ONE
  48. Transplantation of mouse CGR8 embryonic stem cells producing GDNF and TH protects against 6-hydroxydopamine neurotoxicity in the rat
    Tian-wei Liu, Zegang Ma, Yu Zhou, Junxia Xie · 2013 · The International Journal of Biochemistry & Cell Biology
  49. Frontiers in the surgical treatment of Parkinson’s disease
    Michael S. Remple, Yaw Sarpong, Joseph Samir Neimat · 2008 · Expert Review of Neurotherapeutics
  50. Identification of Asp95as the Site of Succinimide Formation in Recombinant Human Glial Cell Line-Derived Neurotrophic Factor
    John O. Hui, David T. Chow, David Markell, John H. Robinson, Viswanatham Katta, Lori Nixon, Byeong S. Chang, Michael F. Rohde, Mitsuru Haniu · 1998 · Archives of Biochemistry and Biophysics
  51. Surgical management of Parkinson's disease: a critical review.
    Danny Tat Ming Chan, Vincent Mok, Wai Sang Poon, KN Hung, Xiaofan Zhu · 2001 · PubMed
  52. Effect of Intranigral Injection of GDNF and EGF on the Survival and Possible Differentiation Fate of Progenitors and Immature Neurons in 6-OHDA-Lesioned Rats
    Zhengquan Yu, Ji-Hui Zha, Hongmei Liu, Yanxia Ding, Yan-Qian Wang, Hongjun Wang, Dianshuai Gao · 2009 · Neurochemical Research
  53. Nerve growth factor induces light adaptive cellular and synaptic plasticity in the outer retina of fish
    Sakineh N. Haamedi, Harvey J. Karten, Mustafa B.A. Djamgoz · 2001 · The Journal of Comparative Neurology
  54. Both glutamate receptor antagonists and prefrontal cortex lesions prevent induction of cocaine sensitization and associated neuroadaptations
    Yong Li, Xiu‐Ti Hu, Timothy G. Berney, A. John Vartanian, Christy D. Stine, Marina E. Wolf, Francis J. White · 1999 · Synapse
  55. NIH 3T3 cells or engineered NIH 3T3 cells stably expressing GDNF can protect primary dopaminergic neurons
    Duanduan Ma, Xiaomin Wang, Ji‐Sheng Han · 2000 · Neurological Research
  56. Trophic Factors as Therapeutic Agents for Diseases Characterized by Neuronal Death
    Vassilis E. Koliatsos, Italo Mocchetti · 1999 · Humana Press eBooks
  57. Novel Gene Therapeutic Strategies for Neurodegenerative Diseases
    Kathleen A. Maguire‐Zeiss, Howard J. Federoff · 2006 · Springer eBooks
  58. New Developments in the Surgery for Parkinson's Disease
    Christopher R. Honey, Robert E. Gross, Andrés M. Lozano · 1999 · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
  59. Parkinson disease and other synucleinopathies
    Thomas Gasser, Thomas Wichmann · 2022 · Elsevier eBooks
  60. The dual role of striatal interneurons: circuit modulation and trophic support for the basal ganglia
    Elliot Wegman, Marlena Wosiski‐Kuhn, Yu Luo · 2023 · Neural Regeneration Research
  61. Critical Aspects of Clinical Trial Design for Novel Cell and Gene Therapies
    Zinovia Maria Kefalopoulou, Icíar Avilés-Olmos, Thomas Foltynie · 2011 · Parkinson s Disease
  62. Administration of prosaposin-derived neurotrophic factor to neural tube defects facilitates regeneration and restores neurological functions
    Sakirul Khan, Akihide Takeuchi, Hiroaki Nabeka, Farzana Islam Khan, Tetsuya Shimokawa, Sota Takanezawa, Takashi Saitou, Takeshi Imamura, Tetsuya Tachibana, Akira Nishizono et al. · 2023 · iScience
  63. Analysis of Acute and Chronic Methamphetamine Treatment in Mice on Gdnf System Expression Reveals a Potential Mechanism of Schizophrenia Susceptibility
    Laoise Casserly, Daniel R. Garton, Ana Montaño-Rodriguez, Jaan‐Olle Andressoo · 2023 · Biomolecules
  64. Of Monkeys and Men: Analysis of the Phase 2 Double-Blind, Sham-Surgery Controlled, Randomized Trial of AAV2-Neurturin Gene Therapy for Parkinson’s Disease
    Daniel E. Huddleston, Stewart Alan Factor · 2011 · Current Neurology and Neuroscience Reports
  65. An Overview of Novel Therapies for Parkinson's Disease
    Stanley Fahn · 1997 · Experimental Neurology
  66. Astrocyte line SVG-TH grafted in a rat model of Parkinson's disease
    Gal Yadid, Nathalia Fitoussi, Noa Kinor, Revital Geffen, Iris Herman Gispan · 1999 · Progress in Neurobiology
  67. Evaluation of the relationship between SORL1 gene polymorphism and Parkinson's disease in the Chinese population
    Ying Wang, Mengting Luan, Xue Li, Jianing Jin, Anmu Xie · 2022 · Neuroscience Letters
  68. Aquaporin 4 beyond a water channel; participation in motor, sensory, cognitive and psychological performances, a comprehensive review
    Seyede Zohreh Jazaeri, Ghorban Taghizadeh, Javad Fahanik‐Babaei, Sepideh Goudarzi, Pegah Saadatmand, Mohammad Taghi Joghataei, Zohreh Khanahmadi · 2023 · Physiology & Behavior
  69. Activation of cultured astrocytes by amphotericin B: Stimulation of NO and cytokines production and changes in neurotrophic factors production
    Akiko Motoyoshi-Yamashiro, Mizuho Tamura, Mitsuaki Moriyama, Katsura Takano, Kenji Kawabe, Hidemitsu Nakajima, Ritsuko Katoh‐Semba, Teiichi Furuichi, Yoichi Nakamura · 2013 · Neurochemistry International
  70. Neurotrophic Factors in Parkinson’s Disease: Clinical Trials
    Arun Kumar Mahato, Märt Saarma · 2024 · Stem cell biology and regenerative medicine
  71. Apoptosis vs Nonapoptotic Mechanisms in Neurodegeneration
    K. A. Jellinger · 2003 · Humana Press eBooks
  72. Biomaterials for Cell Encapsulation: Progress Toward Clinical Applications
    Gurbinder Kaur, Francesco Baino, John C. Mauro, V. Ravi Kumar, Gary Pickrell, Nammalwar Sriranganathan, Steven Grant Waldrop · 2017 · Springer eBooks
  73. Neurotrophic Factor Gene Therapy for Neurodegenerative Diseases.
    MC Bohn, Derek L. Choi-Lundberg · 1998 · eCite Digital Repository (University of Tasmania)
  74. Neuroprotection by a Novel Compound, NS521
    Mette Grønborg, Teit Eliot Johansen, Dan Peters, Philip Kiær Ahring, Jørgen Drejer, Arne Møller, Leif Helth Jensen · 1999 · Journal of Pharmacology and Experimental Therapeutics
  75. Behavioral Assessment in the Unilateral Dopamine-Depleted Marmoset
    Lucy E. Annett, Rachel Smyly, J. M. Henderson, Rosalyn M. Cummings, A. Lisa Kendall, Stephen B. Dunnett · 2000 · Humana Press eBooks
  76. Supramolecular nanostructure mimics GDNF trophic effects in vitro on human dopaminergic neurons
    Oscar A. Carballo-Molina, Alexandra N. Edelbrock, Matías Alvarez-Saavedra, Zaida Álvarez, Timmy Fyrner, Tamara Perez‐Rosello, Zois Syrgiannis, Stacey M. Chin, Nozomu Takata, Madison E. Strong et al. · 2025 · npj Regenerative Medicine
  77. Application of Neurotrophic Factors as a Therapeutic Approach for Neurodegenerative Diseases
    S. Kim, S.Y. Lee, Un Ju Jung, Sang Ryong Kim · 2025 · Experimental Neurobiology
  78. The Use of Neurotrophic Factors as a Promising Strategy for the Treatment of Neurodegenerative Diseases (Review)
    Grigorii Andreevich Fursa, S. S. Andretsova, V. S. Shishkina, Anastasia Denisovna Voronova, Ekaterina Konstantinovna Karsuntseva, A. V. Chadin, I. V. Reshetov, O. V. Stepanova, Vladimir Pavlovich Chekhonin · 2024 · Bulletin of Experimental Biology and Medicine
  79. Lysine (K)-Deacetylase Inhibitors: The Real Next Step To Neuropsychiatric And Neurodegenerative Disorders?
    Tatiana Rosado Rosenstock · 2014 · Zenodo (CERN European Organization for Nuclear Research)
  80. Stem cells and regenerative therapies for Parkinson’s disease
    Roger A. Barker, Farrell · 2012 · Degenerative Neurological and Neuromuscular Disease
  81. Ape1/Ref-1 Stimulates GDNF/GFRα1-mediated Downstream Signaling and Neuroblastoma Proliferation
    Mi-Young Kang, Kweon Young Kim, Young Mi Yoon, Yoonsung Kang, Hong-Beum Kim, Cha Kyung Youn, Dong-Hui Kim, Mi-Hwa Kim · 2009 · Korean Journal of Physiology and Pharmacology
  82. Construction of Targeting Vector for Expressing Human GDNF in Cattle Mammary Gland
    Xueming Zhang, Ying Wu, Fenhua Luo, Huimin Su, Yin Bai, Yue Hou, Boyang Yu · 2009 · Applied Biochemistry and Biotechnology
  83. Stem cells in the adult human brain
    Aminul Islam Ahmed, Malik Zaben, William Gray · 2010 · British Journal of Neurosurgery
  84. Insights from mathematical modeling for convection-enhanced intraputamenal delivery of GDNF
    Elena Aleksandrovna Belova, Christopher L. Shaffer, Patrick E. Trapa · 2017 · Medical & Biological Engineering & Computing
  85. Aspectos moleculares y prospectos de terapias en la enfermedad de Parkinson
    Hebert Luís Hernández-Montiel · 2006 · Redalyc (Universidad Autónoma del Estado de México)
  86. GDNF abates serum deprivation-induced tyrosine hydroxylase Ser19 phosphorylation and activity
    Nobuhide Kobori, Anthony N. Moore, Pramod K. Dash · 2006 · Brain Research
  87. Effect of neurturin on multipotent cells isolated from the adult skeletal muscle
    Patrick Vourc’h, Benjamin Lacar, Laurence Mignon, Paul A. Lucas, Warren Young, Marie‐Françoise Chesselet · 2005 · Biochemical and Biophysical Research Communications
  88. Models in Biology
    Maura C. Flannery · 1997 · The American Biology Teacher
  89. FK506 Protects Dopaminergic Degeneration Through Induction of GDNF in Rodent Brains
    Atsumi Nitta, Rina Murai, Keiko Maruyama, Shoei Furukawa · 2002 · Advances in behavioral biology
  90. Neurotransmitter and Growth Factor Alterations in Functional Deficits and Recovery Following Traumatic Brain Injury
    Anthony E. Kline, Larry W. Jenkins, Hong Qu Yan, C. Edward Dixon · 2001 · Springer eBooks
  91. Return of the native: deducing the normal function of the RET proto-oncogene
    Amanda Capes‐Davis, Bruce G. Robinson · 1999 · Current Opinion in Endocrinology & Diabetes
  92. EFFECTS OF GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR (GDNF) ON STEM/PROGENITOR CELL PROLIFERATION AND DIFFERENTIATION
    Yan Chen · 2005 · UKnowledge (University of Kentucky)
  93. Medical Treatment of Parkinson Disease
    Stanley Fahn, Joseph J. Jankovic, Mark Hallett, Peter G. Jenner · 2007 · Elsevier eBooks
  94. Parkinson's Disease
    Daniela Berg, Rejko Krüger, Olaf Rieß, Peter Franz Riederer · 2007 · Springer eBooks
  95. Minor Immunoreactivity in GDNF‐, BDNF‐, or NT‐3‐Treated Substantia Nigra Allografts
    Masaki Shinoda, Barry J. Hoffer, Lars Olson · 1997 · Neural Plasticity
  96. Modeling and synthesis of non-cyclic derivatives of GPI-1046 as potential FKBP ligands with neurotrophic properties
    Liqin Zhao, Hongying Liu, Lili Wang, Song Li · 2006 · Bioorganic & Medicinal Chemistry Letters
  97. Globus pallidus plays a critical role in neurotrophic factor induced functional improvements in hemiparkinsonian monkeys
    Tao Xin, Yi Ai, Greg A. Gerhardt, Don Marshall Gash, Zhiming Zhang · 2008 · Biochemical and Biophysical Research Communications
  98. Exercise Training and Rehabilitation of the Brain in Parkinson´s Disease
    Muhammed D. Al-Jarrah · 2013 · Clinical Medicine Research
  99. Neurotrophic factors for the investigation and treatment of movement disorders
    Justo Garcı́a de Yébenes, Marina P. Sánchez, María A. Mena · 2003 · Neurotoxicity Research
  100. Cellular Localization of gdnf in Adult Zebrafish Brain
    Chee Ern David Wong, Khang Hua, Simon Monis, Anwar Norazit, Suzita Mohd Noor, Marc Ekker · 2020 · Brain Sciences